FDA – Penn Program on Regulation

Tag: FDA

How An Abortion Pill Ruling Could Threaten The FDA’s Regulatory Authority

April 11, 2023• PPR Affiliates in the News

Read More →

A New Alzheimer’s Drug Will Cost $26,000 a Year. Who Will Be Able to Get it?

January 9, 2023• PPR Affiliates in the News

...

Read More →

Alzheimer’s Drug That Slows Cognitive Decline Gets FDA Approval

January 6, 2023• PPR Affiliates in the News

...

Read More →

TikTok Trend Wipes Out Ozempic Supply, Leaving People With Diabetes Dizzy, Scared

December 23, 2022• PPR Affiliates in the News

Read More →

Preterm Birth Drug Makena Ignites Argument Over Health Equity

November 10, 2022• PPR Affiliates in the News, Uncategorized

...

Read More →

Bu’s COVID Tinkering, FDA on Trial, & Why It’s Hard to Take Drugs off the Market

October 20, 2022• PPR Affiliates in the News

...

Read More →

FDA Seems Poised to Approve a New Drug for ALS, but Does it Work?

September 21, 2022• PPR Affiliates in the News

Read More →

The Debate over a New ALS Drug Harkens Back to the Aduhelm Controversy

September 8, 2022• PPR Affiliates in the News

Holly Fernandez Lynch in Washington Post, Sep 8, 2022...

Read More →

FDA Still Skeptical of ALS Drug Ahead of High-Stakes Meeting

September 2, 2022• PPR Affiliates in the News

Holly Fernandez Lynch in WRAL, Sep 2, 2022...

Read More →